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Recent attempts to clarify the pathogenesis of pharmacoresistant epilepsies arrive at the conclusion that intractable epilepsies 
might be prevented by earlier, more effective pharmacotherapy. In this paper the problem of intractability is examined from a 
psychological point of view. 
Sixteen patients with intractable epilepsies were trained in techniques of self control (SC) in addition to ongoing pharmaco- 
logical treatment. The SC training consisted of detailed self observation which aimed at identifying warning signals of a beginning 
seizure and seizure-provoking factors and the development of ‘counter measures’ (behavioural measures to interrupt a beginning 
seizure and to neutralize provoking factors). 
After SC training. all those patients who successfully managed to deal with their identified problems (strong psychic stress 
and/or poor intuitive SC abilities) achieved a significant improvement of seizure control: 68% obtained 80-100% reduction and 
12% obtained 60-70% reduction of seizures. None changed for the worse. 
These findings suggested that psychological methods of seizure control can contribute to improving long-standing intractable 
epilepsies. Offered early in the process of epilepsy they may even help to prevent the development of intractability. A new kind 
of polytherapy is proposed, consisting of a combination of pharmacological and SC therapy. 
KCY WO&: intractable epilepsies; self control; warning signals; seizure provoking factors; psychic stress; counter measures. 
INTRODUCTION 
In spite of recent developments of new antiepileptic 
drugs 3040% of patients with epilepsy do not become 
seizure-free using currently available anticonvulsants. 
Several recent attempts have been made to better un- 
derstand the pathogenesis of and to help prevent the 
development of intractable epilepsies. 
The traditional view has been that patients with in- 
tractable epilepsies have more severe epilepsies-too 
severe to be controlled with currently available drugs. 
Reynolds and others I-3 consider the ‘alternative or ad- 
ditional possibility that chronicity is not inevitable, that 
epilepsy should be viewed as a process and that to 
some extent intractable epilepsy might be prevented 
by earlier more effective treatment’“. Seizure control 
should be obtained within the first 2 years of treatment5. 
Bourgeois6 argues on the same line: ‘intractability can 
be defined in broad terms as the failure of optimal 
therapy’. In his study, ‘optimal therapy’ meant optimal 
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pharmacological treatment with available antiepileptic 
medication. 
Heinemann’ stressed that many drug-resistant 
epilepsies start in childhood and concludes that ‘in 
most cases drug-resistance appears to be an acquired 
phenomenon which may well have to do with effects 
of seizures on the developing brain’. Though strongly 
supporting the idea of epilepsy as a process as well, 
Heinemann’ seems less optimistic than Reynolds’ and 
Bourgeois6 concerning the efficacy of already available 
anticonvulsants. He proposes detailed studies to better 
understand the development of drug-resistant epilep- 
sies and to conceive strategies ‘which not only increase 
the likelihood that new anticonvulsants improve quality 
of life by improving seizure control with fewer side- 
effects but also prevent progression of epilepsies into a 
pharmacoresistant state. Drugs are also required which 
provide seizure control for such patients”. 
Besides these medical and pharmacological consid- 
erations to reduce or prevent pharmacoresistance in 
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epilepsy, there is a paucity of systematic attempts to 
reduce seizure frequency in patients with intractable 
epilepsies with the help of psychological methods of 
seizure control. 
In this paper a research project is presented in which 
20 patients, most of them with pharmacoresistant 
epilepsies, were offered training in techniques of ‘self 
control’ (SC) (non-medical, behavioural measures of 
seizure control) in addition to ongoing pharmacolog- 
ical treatment. Though the study did not address the 
question of pharmacoresistance in a direct way, suc- 
cess and failure of the SC programme provided both 
an insight into conditions which may lead to problems 
of seizure control, including pharmacoresistance, and 
new ideas on how to reduce seizure frequency in in- 
tractable epilepsies or even to prevent the development 
of pharmacoresistant epilepsies. 
MATERIALS AND METHODS 
The treatment model of self control 
Figure 1 shows the main aspects of SC treatment9-16. 
Starting from the medical diagnosis ‘epilepsy’, thera- 
pist and patient try to analyse the prephase and the very 
beginning of the seizure in as much detail as possible. 
The focus is on the ‘warning signals’ ’ ’ of the seizure 
(the ‘aura’ or other feelings or warnings) and on the 
seizure-provoking factors (triggering factors) which in- 
crease the risk of seizure development for the indi- 
vidual patient. Provoking or promoting factors may 
consist of external (situational) conditions or inter- 
nal (emotional) states of the patient or a combina- 
tion of both. On the basis of these additional diag- 
nostic data behavioural measures of seizure control, 
so-called ‘counter measures’ 13, are developed: either 
counter measures to directly interrupt or arrest”’ a 
beginning seizure, or measures to avoid, compensate 
for, or actively eliminate provoking factors. 
At best, a first improvement of the seizure situation 
can be achieved within three to five sessions and then 
can be consolidated during another five to ten sessions 
of SC (see the thick arrow to the box ‘Self control’ 
in Fig. 1). In most cases, however, there is need for 
a longer learning process in order for the patient to 
become more sensitive to warning signals, to identify 
complex patterns of provoking factors and to create and 
practice effective counter measures (symbolized by the 
backwards arrows in Fig. 1). In some cases it may hap- 
pen that warning signals and provoking factors have 
been identified and effective counter measures have 
been developed, but the patient makes no use of them. 
The patient may let the onset of the seizure continue 
without any effort to interrupt it or may even increase 
the risk of seizure by actively bringing about critical 
situations. Then an investigation takes place into what 
possible psychological function(s) the seizures may 
serve. Sometimes this may require a broader frame 
of psychotherapy. (For more detailed information on 
the SC programme applied in this study, see references 
14-16.) 
Subjects 
The 20 subjects participating in the study came 
from neurological outpatient units of different hospi- 
tals. Criteria for inclusion were: (a) clinical electro- 
encephalograph (EEG) evidence of epilepsy, (b) no 
progressive brain disease, (c), illness of at least 3-year 
duration, (d) ability to understand and follow instruc- 
tions, (e) a minimum of four seizures a month, (f) recall 
of the start of the seizure (i.e. any kind of ‘warning sig- 
nal’ and/or early seizure symptoms), (g) unchanged an- 
ticonvulsant treatment for at least 1 month prior to par- 
ticipation and no changes for at least another 6 months 
during SC therapy. For pragmatic reasons (limited time 
to recruit patients) and because of the exploratory na- 
ture of the study we accepted that criteria (e)-(g) were 
not met by all patients. 
The following presentation is based on 16 patients 
whose epilepsies had been diagnosed as pharmaco- 
resistant by their physicians. In 1 1 patients pharmaco- 
resistance had been diagnosed after treatment with at 
least three different antiepileptic drugs (AEDs) with the 
maximal tolerated dose in monotherapy and/or poly- 
therapy. The remaining five patients had been treated 
with one or two AEDs without becoming seizure-free 
and no other AED had been assumed to improve seizure 
control. 
Nine of the patients were male, seven female. Nine 
of them were adolescents, aged 12- 17 years, the other 
seven were adults, aged 21-43 years. Half of the pa- 
tients had complex partial seizures, in addition, three 
of them had secondarily generalized grand ma1 (GM) 
seizures, four patients suffered from GM seizures alone 
(two primarily generalized, two secondarily general- 
ized). The remaining four patients had simple partial 
seizures, three of them with additional secondarily gen- 
eralized GM seizures (see Table 1). 
Seizure frequency varied from one seizure within 6 
weeks to 150 seizures per month. All patients had at 
least a 5-year history of epilepsy, the majority of them 
much longer (average duration: 9.9 years). The pre- 
scribed AEDs at the outset of the study are shown in 
the last column of Table 1. Twelve of the patients were 
treated with one AED (mostly a high-dose monother- 
apy), the remaining four patients were treated with a 
combination of two AEDs. 
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Extended diagnosis 
I 
Counter measures 
Counter measures 
to interrupt a 
beginning seizure 
Function of I-- seizures (analysis 
( psychotherapy) 
Function of -7 seizures (analysis 
psychotherapy) ) 
Fig. 1: The treatment model of self control. The boxes represent the different treatment components, and the arrows symbolize 
the possible parallel or sequential order of the treatment components. A plus or a minus at the end of an arrow signifies 
successful or unsuccessful outcomes of the treatment. 
Course and duration of SC therapy 
For all patients the conditions for SC were examined 
and counter measures were developed according to the 
scheme outlined in Fig. 1. The period of continuous 
SC treatment varied from 3 to 30 months with an aver- 
age duration of 18 months; during this time the patients 
participated in 5-40 sessions with an average of 20 ses- 
sions. At the beginning all patients were offered four to 
six individual sessions at 1- to 2-week intervals to find 
out their individual (special) conditions for self control. 
Then individual and group sessions alternated at 2- to 
4-week intervals. In most cases there were ‘booster ses- 
sions’ 6 and 12 months after the end of the treatment 
phase, and then a telephone follow-up after 24 months 
to ascertain long-term seizure frequency and use of SC 
techniques. 
Case report 
To illustrate the process of SC therapy, one patient’s 
course of treatment will be described in more detail. 
Sebastian has a frontal-lobe epilepsy and suffers from 
complex partial seizures which usually generalize into 
tonic-clonic GM seizures. We first met when he was 16 
years of age, during his stay at the Children’s Hospital 
to improve his antiepileptic drug regimen. This attempt 
did not lead to a better seizure control (as many had not 
previously), and he was offered participation in the SC 
programme. 
The behaviour and seizure analysis revealed the fol- 
lowing main points. 
(1) Seizures occurred repeatedly in situations of con- 
flict, in particular during confrontations with his 
mother who was the most important person after 
the separation of his parents. The first GM seizure 
developed at the age of 11 years during a heavy 
conflict between his parents. 
(2) Sebastian had identified warning signals that pre- 
ceded his seizures: he felt tickling in his left arm. 
(3) Surprisingly, he had already developed a strategy 
to counteract his seizures: he stopped breathing for 
a moment, put his hands to his temples or pressed 
the bridge of his nose with two fingers of his left 
hand, closed his eyes tightly and concentrated by 
saying to himself: ‘I don’t want to have a seizure 
now’ or ‘I don’t need a seizure’. This counter mea- 
sure proved to be effective, when he really did not 
want to have a seizure. He admitted, however, that 
he sometimes let a seizure continue to develop to 
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Table 1: Patient characteristics at the beginning of the study (N = 16) 
Seizure frequencyb 
Patient Gender 4s Seizure type” Per month (Range) Duration of illness (years) AEDC 
1 m 17 co-+ GM ca 20 (3-5/w) 6 PB + PHT 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
12 
13 
14 
1.5 
f 
f 
m 
m 
f” 
m 
f 
m 
m 
m 
m 
21 cp+GM ca 6 (2-6/m) 
26 GM prim ca 1 (0-2/m) 
31 sp+ GM ca 8 (o-d/W) 
14 cP ca 9 (S-IO/m) 
16 cP ca 6 ( I -2/W) 
25 GM set ca 10 (2-3/w) 
24 sp+GM ca 1.5 ( I-2/m) 
I5 cP ca 150 (4-6/d) 
16 cP ca 3 (IA/m) 
15 cp+GM ca 7 (2-12/m) 
12 GM set ca 8 ( I -3/w) 
33 sp+GM ca 0.66 (0-2/m) 
43 sP ca IO (24/W) 
I5 GM prim ca 4 (3-5/m) 
19 
14 
I4 
PRM 
PB + VPA 
CBZ 
PHT 
CBZ 
CBZ 
CBZ 
CBZ 
PHT 
PHT 
PHT + GVG 
CBZ 
CBZ 
CBZ 
16 f I7 cP ca 25 (5-7/W) 9 PHT + AZA 
a cp: complex partial seizures; sp: simple partial seizures; GM: grand mal seizures: GM prim: primary GM: GM set: secondary GM: 
cp/sp + GM: complex or simple partial seizures generalizing 10 GM. 
b In addition to the estimated average seizure frequency per month rhe range of seizures is given in brackets: e.g. (3-5/w): 3-S seizures per 
week; (4-6/d): 4-6 seizures per day. 
’ AZA: Acetazolamid; CBZ: carbamazepine; CVG: vigabatrin: PB: phenobarbital; PHT: phenytoin; PRM: primidon; VPA: valproate. 
frighten his mother or to be allowed to skip a test 
at school. 
During a further stay in hospital Sebastian was en- 
couraged, and agreed, to try his techniques of SC in 
a more systematic way. He accomplished a seizure- 
frequency reduction from five to one or two GM 
seizures per week. 
To come to terms with the critical situations with 
his mother he was offered continued SC therapy 
after discharge from hospital. This outpatient therapy, 
though fully agreed upon by Sebastian, was later pre- 
vented by unforeseen reasons: shortly after Sebastian’s 
discharge from the hospital he had to move with his 
mother into the apartment of her new friend. The re- 
location to another district implicated a school change 
which in turn caused massive learning problems for 
him, hence his seizure control deteriorated. 
He needed inpatient treatment again, and this time 
the decision was made to send him to an epilepsy cen- 
tre away from his home town. There he was not only 
offered an integrated medical-psychological treatment 
programme but also could work on his profound psy- 
chological problems at a safe distance from his mother 
and all the stressing social and situational factors. 
Sebastian learned to deal with conflicts in a more 
courageous way, he gained self confidence and learned 
to express aggression in a more open manner-instead 
of indirectly reacting with a seizure. He applied his 
counter measures actively and successfully. After three 
seizure-free weeks, and a 2-month stay in the epilepsy 
centre, he was told of his discharge: he reacted with 
a GM seizure. His fears of returning home were dealt 
with. Additionally he was offered a place in a special 
boarding school 10 kilometres from his mother’s resi- 
dence where he could stay during the week: he agreed 
to this. 
Only a few weeks later he moved to his new home, 
the boarding school. The relationship with his mother 
became less tense and he could express himself in an 
open way. For weeks he remained seizure-free, abort- 
ing the majority of onset of seizures successfully by 
his counter measure. This situation of seizure control 
remained stable: during the last 2 years he has had only 
a few GM seizures. 
Sebastian’s case demonstrates in an impressive way 
how strongly psychosocial factors can influence the 
course of epilepsy in a negative or positive way. Situ- 
ations of psychic stress, in particular feelings of help- 
lessness in the context of conflicts with a more pow- 
erful person, not only had a seizure-provoking effect 
for Sebastian, but also led him to give up his own intu- 
itive means of seizure control. On the other hand, deal- 
ing successfully with the problematic situations both 
weakened their seizure-provoking effect and reduced 
the functional value of seizures. Sebastian is no longer 
in need of seizures to resolve conflicts. The anticonvul- 
sant medication, along with his SC techniques, enabled 
a satisfactory seizure control to develop. 
RESULTS 
The other patients’ courses of SC treatment mostly 
were less dramatic and often much shorter. Neverthe- 
less, we identified similar factors which proved to be 
relevant both in respect to the initially existing seizure 
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Table 2: Psychic factors in patients with pharmacoresistant epilepsies (N = 16) 
Functional value of 
Patient Gender Age Psychic stress” Seizuressb Unfavourable reactiona 
I m 17 Conflict + - 
2 f 21 Disappointment + - 
3 f 26 Conflict + - 
4 
7 
31 Conflict + - 
5 14 Neglect + - 
6 m I6 Loneliness, death of grandmother + Fear of seizures 
7 25 Fear, helplessness + Fear of seizures 
8 t: 24 Pressure to perform + Fear of seizures 
9 
Y 
I5 Pressure to perform - Fear of seizures 
IO 16 Rage/conflict - - 
II f IS Fear/guilt, aura-related fear - Fear of seizures, fascination of aura 
I2 m 12 - - Fear of seizures 
13 m 33 - - Fear of seizures 
I4 m 43 - - - 
I5 m I5 - - - 
I6 f I7 - - - 
3 -: Factor not identified. 
b f: Functional value identified. 
intractability and in respect to the eventually achieved 
seizure control by SC training at the end of the study. 
Two groups of factors can be differentiated: ‘psychoso- 
cial factors’ and ‘self-control factors’. 
Psychosocial factors 
Table 2 gives an overview of the psychosocial factors 
identified as having stressing, seizure-facilitating, or 
otherwise unfavourable effects on the patients’ process 
of epilepsy. 
Psychic stress. In 1 1 of 16 patients seizures oc- 
curred repeatedly in situations of strong psychic stress. 
Amongst these seizure-facilitating or provoking fac- 
tors were conflicts, as in the case of Sebastian (shown 
in line 1 of Table 2), disappointment, feelings of ne- 
glect, fear and rage, or pressure to perform. 
Functional value ofseizures. In eight of the 11 patients 
with identified strong psychic stress factors, seizures 
had acquired a functional value: either bring to an end 
the stressful situation, e.g. stop conflict with an im- 
portant person (as was the case with Sebastian), to at- 
tract more attention or to release high demands. Besides 
being an unpleasant, frightening event, in these cases 
seizures offered some positive short-term effect to the 
patients. This kind of functional value may render the 
treatment of seizures more difficult. 
Unfavourable reactions. There was a third psycho- 
logical aspect, the meaning of which we recognized 
only during the course of our study: the so-called ‘un- 
favourable reactions’ of the subject. Unfavourable re- 
actions are reactions which the patient shows during 
situations that carry a high risk for seizures or at the 
onset of a seizure, and by which the development of 
the seizure is supported or accelerated. 
In seven of the 16 patients such reactions that unwill- 
ingly led to increase of seizure risk could be identified. 
In most cases patients were afraid of their seizures and 
started hyperventilating or exhibited fear and conse- 
quent physiological changes which in turn increased 
seizure risk. Three patients experienced the additional 
fear of embarrassment caused by a seizure besides the 
direct fear of seizures. In all these cases ‘warning sig- 
nals’ had lost their positive function of triggering some 
kind of ‘counter measure’ to control the seizure. They 
were misinterpreted as announcing unavoidable dan- 
ger, became triggering factors for fear and helplessness, 
and, by that, additional triggering factors of seizures. 
One patient had a particularly difficult condition. At 
the onset of her seizures she had an aura with strong 
feelings of undefinable fear. She thought she could get 
rid of her seizures only when she was able to find out the 
reason of this aura-conditioned fear. By this idea she 
felt magically attracted into the aura. From the begin- 
ning she was unable to resist the seizure as well as not 
initiating any counter measure to actively interrupt it. 
Self control factors 
The second group of factors which may contribute to 
pharmacoresistant epilepsies interfere with the prac- 
tical performance of SC techniques. This statement is 
based on the assumption that a number of patients with 
266 C. Schmid-ScMnbein 
Table 3: Factors that limit self control abilities in 16 patients 
with Dharmacoresistant eoileosies 
a 3 
Missing/unclear Unrecognized Missing/ineffective 
warning provoking counter 
Patient signals” factorsb measuresC 
I x xx X 
2 X XX X 
3 xx xx xx 
4 X X 
5 xx X 
6 X X X 
7 X X 
a 
8 X xx xx 
9 X X X 
IO X X X 
II X X xx 
12 ? X 
13 xx 
14 xx xx xx 
I5 xx xx 
16 X XX xx 
xx: Missing; x: unclear; . : clear. 
b xx: Unrecognized; x: uncertain;. : no; ?: no information. 
’ xx: Missing: x: inneffective. 
epilepsy spontaneously try to defend themselves 
against their seizures, either by aborting their seizures 
using counter measures or by intuitively avoiding sit- 
uations that precipitate seizures. Thus, they uncon- 
sciously support the effect of the anticonvulsant medi- 
cation. However, in cases in which these intuitive coun- 
teractions are missing or suppressed the effect of the 
medication may prove to be insufficient. We identified 
three factors that limit SC (see Table 3). 
Missing or unclear warning signals. 
l Two of our study patients had no warning signals 
due to the type of epilepsy (primary GM, GM dur- 
ing sleep) and one patient due to his AED. These 
patients had no chance to use a counter measure to 
interrupt the onset of a seizure. 
l Of the remaining 13 patients only three had clear 
aura-like feelings at the beginning of the study 
whereas the other 10 patients had unclear, very 
weak or very rare warning signals. 
l Three patients had the additional problem that they 
could not differentiate seizure warnings from warn- 
ings of circulatory dysregulation. 
Patients with unclear warning signals not only have a 
low chance to interrupt the onset of a seizure, but they 
often give up using their counter measure systemati- 
cally because they become insecure and disappointed. 
Unrecognized provoking factors. Unrecognized or ig- 
nored provoking factors cannot be compensated. 
l About half of the patients (five of 11) with psychic 
triggering factors, described above, at the begin- 
ning of the study had never thought of a possible 
relationship between psychic stress and seizures, 
and had never tried to diminish their stress in order 
to lower the seizure risk. 
l Besides psychic stress we identified two additional, 
previously unrecognized, seizure-provoking fac- 
tors. In one patient high visual input in combination 
with drowsiness (in part conditioned by the AED) 
increased seizure risk to a considerable degree. In 
the other patient seizures tended to develop when 
he experienced a ‘split in concentration’ (i.e. situ- 
ations in which the patient tried to perform more 
than one activity in parallel, situations of ‘divided 
attention’). 
Missing, ineffective or unsystematically applied counter 
measures. 
At the beginning of the study four patients had in- 
effective counter measures (CM). 
Three patients performed their effective CM only 
occasionally (as was true for Sebastian). 
For two patients both conditions applied: they oc- 
casionally used their ineffective CM. 
There was no patient at the beginning of the study 
with an effective CM used systematically. 
Nearly half of the patients (7 of 16) had no CM at 
all. Whereas three of them had no chance to use 
a CM because they had no warning signals (see 
above), the remaining four patients developed no 
CM despite the presence of warning signals. 
It seems remarkable that three of these four patients 
without CM were adults. Whereas nearly all adoles- 
cents spontaneously developed CMs and actively tried 
to abort their seizures, these three adults did not even 
develop the idea of a ‘counter measure’. On the con- 
trary, two of them were convinced that their seizures 
were unavoidable. They expected them and prepared 
themselves to bear the seizure: one patient laid down, 
waiting until ‘all was over’. All three patients suc- 
ceeded in finding a CM during the course of the study 
with which they could improve control to a consider- 
able degree. 
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Table 4: Effect of self control treatment 
Treatment of 
psychic (stress) Training of Decrease in seizure 
DISCUSSION AND CONCLUSIONS 
Patient factors” SC-skills” frequency (%)b 
I + + SO-90 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
12 
13 
14 
15 
+ 
-t 
+ 
- 
(-4-j 
+ 
+ 
i 
+ 
(+) 
(+) 
+ 
+ 
+ 
(+) 
+ 
+ 
+ 
+ 
- 
+ 
+ 
+ 
SO-90 
100 (2.5 years) 
SO-60 
30-40 
(80) 
100 (2 years) 
So-60 
80-90 
80-90 
- 
100 (3 years) 
60 
80 
20 
16 (+) - 
a +: Successful treatment/training: (+): limited (transitional) 
success of treatment/training: -: treatment/training without 
success;. : treatment/training not applied. 
b 80-90: 80-90% decrease of seizure frequency for at least 6 
months; IO0 (2.5 years): seizure-free for 2.5 years; (80): 
transitional decrease of seizure frequency: -: no change in seizure 
frequency; bold figures represent the I I successfully treated 
patients mentioned in the discussion. 
The effect of the SC treatment at the end of the 
study can be summarized as follows (see Table 4). All 
patients who identified illness-related problems (psy- 
chosocial factors and/or limiting SC factors) and suc- 
cessfully managed to deal with these problems, were 
able to achieve much better seizure control. This ap- 
plied to 11 of the 16 patients (68%) by the end of the 
study (see bold figures in the last column of Table 4). 
Eight patients (50%) obtained an 80-100% reduction of 
their seizures, three of them (19%) are even seizure-free 
(for 2,2.5 and 3 years). Three other patients improved 
seizure control by 50-60%. 
In nine of the 11 improved patients the improvement 
of seizure control could be obtained by parallel success- 
ful treatment of psychic factors and successful teaching 
or improvement of SC skills (indicated by + in columns 
2 and 3 of Table 4). In addition, there are two patients 
(cases 3 and 14) who obtained a considerable success 
by only one kind of treatment; one of them even became 
seizure-free (for 30 months). 
Of the remaining five patients (3 1%) two achieved 
only low (20-30%) seizure control, another patient 
high, but only temporary, control, and two patients al- 
most no improvement of seizure control. There was 
not a single case of change for the worse during SC 
treatment. 
The effect of the SC treatment was observed for at 
least 6 months (time of first follow-up), in most cases 
for 12 months (time of second follow-up), or even 
longer (up to 3 years). 
Almost 70% of the 16 study patients with long-term in- 
tractable epilepsies were able to improve their seizure 
control to a considerable degree and with long-lasting 
effects. This was obtained by dealing with the seizure- 
provoking, situational and psychic stress factors and, if 
necessary, the functional value of seizures, by the over- 
coming of unfavourable reactions to warning signals 
and by developing-improving-individually tailored 
SC techniques to interrupt the outset of seizures. 
As the approach to SC consists of a complex inte- 
grated therapy programme, it is difficult to determine 
the effect of each single SC component. However, this 
lack of specificity cannot annihilate the summarized 
positive result of the study that two-thirds of the pa- 
tients, after many years of unsuccessful pharmacolog- 
ical treatment, could improve their seizure situation 
significantly while additionally applying non-medical 
behavioural measures of seizure control. We hope that 
these findings will encourage more SC treatment in 
more patients with epilepsy and will produce a broader 
database, which then can be analysed in a more detailed 
methodologically satisfying way. 
From the fact that in most of our patients psychic 
stress factors were identified and could be improved 
by SC treatment, it could be asked whether these pa- 
tients did not only have epileptic seizures but had 
non-epileptic (pseudo-) seizures as well and SC treat- 
ment improved the non-epileptic seizures in particular. 
But, as mentioned before (see methods), all patients 
had clear clinical and EEG evidence of epilepsy. In 
their long history of illness none of the patients had 
ever been diagnosed as having additional non-epileptic 
seizures. Beside this, it is generally accepted that psy- 
chic stress can be a risk factor for genuine epilep- 
tic seizures’* “7 “* t8-“. Antibi and Bird*’ differentiate 
between stress factors that evoke, or only facilitate, the 
development of epileptic seizures. They emphasize that 
sometimes it may be extremely difficult to show the re- 
lationship between stress factors and seizures, because 
stress may increase seizure liability, but a seizure de- 
velops only when one or more additional factors (e.g. a 
particular stimulus) intervenes. The authors propose an 
‘interactional model’ of seizure development ‘wherein, 
assuming a system is sensitive to a particular state or 
stimulus, the production of a seizure is dependent on 
the presentation of the stimulus . . . and the state of the 
system’“. 
This study offers detailed empirical evidence for 
the many variants of psychic stress which altered the 
state of our patients’ system. The relationship be- 
tween psychic stress and seizures could be shown to 
be twofold: the presence of stress factors at the begin- 
ning of the study related to a high seizure rate-the 
successful treatment of stress factors during the course 
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Table 5: Change of antiepileptic drugs (AEDs) during SC-treatment 
Treatmenl of psychic Decrease in seizure frequency 
Patient 
I 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
(stress) factors” 
+ 
+ 
+ 
+ 
- 
(f) 
+ 
+ 
+ 
+ 
Training of SC skills” Change of AEDb (%)’ 
+ + 80-90 
+ 
+ 
+ 
(f) 
+ 
+ 
+ 
+ 
u 
+U 
80-90 
100 (2.5 years) 
SO-60 
+* 
u 
-+ 
3040 
(80) 
100 (2 years) 
SO-60 
80-90 
80-90 
II 
12 
13 
14 
15 
(+) 
+ 
+ 
(+) 
- 
+ 
+ 
+ 
- 
i 
u 
- 
- 
100 (3 years) 
60 
80 
20 
16 (+) - 
a +: Successful treatmentitraining: (+): limited (transitional) success of treatmcntkaining: -: treatment/training without success: .: 
IreatmentItrainin~ not applied. 
b +: Change of AED with positive effect (decreae in seizure frequency): -: change of AED without effect on seizure frequency:.: no change 
of AED: 8: reduction of AED. +*: change of AED instead of SC. 
’ 80-90: R&90% decrease of seizure frequency for at least 6 months: 100 (2.5 years): seizure free for 2.5 years: (80): transitional decrease of 
seizure frequency: -: no change in seizure frequency: bold tigures represent the I I successfully treated patients in the discussion. 
(4 .) Another patient (case 15) only had GM seizures 
which began during sleep and no clear provoking 
factors could be identified. 
(5 ) The fifth patient (case 16) had very weak warning 
signs at the beginning of the study which became 
even weaker after a change in her antiepileptic med- 
ication. 
of the SC programme decreased the rate and sever- 
ity of the seizures. In addition, Fenwick” and Fenwick 
and Brown” present a theoretical neurophysiological 
explanation of the effect of behavioural measures on 
seizure control by referring to an epilepsy model de- 
veloped by Lockard”. 
The five patients with only poor or no improvement 
of seizure control do not disqualify the approach of self 
control. On the contrary, these cases can be explained 
in line with the approach. In all five patients adequate 
SC treatment could not be realized for the following 
different reasons. 
(1) One patient (case 6, Table 4) decided to change 
medication and stop SC treatment. 
(2) In case 5 there were strained relationships between 
family members: these could not be changed during 
the course of the study. 
(3) One patient (case 1 1) had very strong and frighten- 
ing aura feelings which prevented her from apply- 
ing a control mechanism. 
The first three reasons represent unforeseen compli- 
cations, which could not be treated within the frame- 
work of the study. The fifth reason, however, points to 
an interesting and central aspect of SC which up to now 
has been neglected in studies of epilepsy: the possible 
interplay between SC and AED. 
Though our study was not designed to examine this 
aspect, a closer look at the data reveals some more in- 
formation on this topic which will be mentioned briefly. 
During the later phase of SC treatment 11 patients 
(nearly 70%) had changes in their antiepileptic medica- 
tion. Except the one patient (case 6) mentioned above, 
who decided to change medication and stop SC, all 
other changes were decided upon by the patient, the 
physician and the SC therapist. Most of the patients 
agreed to inclusion criterion (g) of the study, i.e. to 
keep medication constant during SC treatment for at 
least 6 months. After that time, however, most of them 
wanted to continue searching for their optimal AEDs 
(in addition to SC therapy). 
Table 5 shows type and effect of changes in medi- 
cation (column 4) in relation to type and effect of SC 
treatment (columns 2 and 3). In three cases (11, 15, 16) 
no positive effect was obtained by the change of med- 
ication. In three cases the change of AED improved 
the patient’s possibilities of applying SC techniques 
and by that-with some weeks delay-seizure control 
improved as well. In two cases (1 and 3) the change 
had been from phenobarbital (PB), which has a strong 
sedative effect, to another less-sedating drug (lamot- 
rigine (LTG) or valproate (VPA)) which made the pa- 
tients more alert and enabled an earlier initiation of 
the control techniques. In the third case (10) warning 
signs which had disappeared under sulthiame (SLT) 
Psychological seizure control 
reappeared after a change to LTG. The remaining four 
patients had no change of type of drug but a partial 
reduction of their medication (see Q in column 4 of Ta- 
ble 5). Following dose reduction all four patients were 
able to improve their SC techniques and achieved fur- 
ther improvement of seizure control. One of them has 
been seizure-free for 2 years (under a minimal dose of 
400 mg CBZ). These examples support the hypothesis 
that antiepileptic drugs may influence SC abilities and 
thus may have indirect effects on seizure control. 
In summary, the presented findings support the idea 
of Reynolds, Bourgeois, Heinemann and others that 
epilepsy should be viewed as a process. At the same 
time the idea of process is further elaborated. Instead 
of dealing with ‘the process of epilepsy’ in general, 
this investigation dealt with the individual processes of 
patients with epilepsy. The approach of SC addresses 
the subject of the individual process. It aims at helping 
patients with epilepsy to learn to observe, understand 
and change their individual circumstances of seizure 
development. It activates the patients’ own resources 
to increase seizure control-in addition to the pharma- 
cological treatment of seizures. 
Given the considerable success of non- 
pharmacological SC treatment in the I6 patients pre- 
sented in this paper, and accepting possible interactions 
between psychological (behavioural) and pharmaco- 
logical treatment effects in epilepsy. one has to ask if 
it is adequate to use the term ‘intractable’ or ‘phar- 
macoresistant’ to characterize these cases; the term 
‘difficult-to-treat’ is suggested instead. 
Epilepsies have many causes and many factors- 
known and unknown-that affect their further course 
of development. ‘Difficult-to-treat’ epilepsies are prob- 
ably difficult to treat because particularly numerous 
factors are involved. Therefore, to control these com- 
plex processes of epilepsy a multimodal approach 
with well-coordinated different treatment components 
should be offered. Traditional pharmacological treat- 
ment alone-in monotherapy or in polytherapy-runs 
the risk of missing relevant factors. 
An optimal therapy would be another kind of poly- 
therapy consisting of a combination of pharmacologi- 
cal and SC therapy. This kind of synergistic treatment 
would be most effective if offered as early as possible 
after failure of first-choice drugs in monotherapy. With 
reference to Reynold’s statement at the beginning of 
this article, it should be offered within the first 2 years 
of treatment-much earlier than it was offered to the 
study patients presented here. 
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